Fundraising FoxAtheroNova
Irvine, US
Find your way into AtheroNova
Sign up to see every warm intro you have to AtheroNova
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AtheroNova team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
TW
Thomas W. GardnerExecutive
MS
Mark SelawskiExecutive
Board
CD
Chaim DavisBoard director
FK
Fred KnollBoard director
GF
Gary FreemanBoard director
BR
Boris RatinerBoard director
JM
Johan M SpoorBoard director
AP
Alexander PolinskyBoard director
PD
Paul DiPernaBoard director
Reported raises · per SEC filings
Form D private placements$2.4M disclosed across 2 rounds · 2014
▶$500KraisedSep 2014 · 7 investors · PharmaceuticalsRule 506(c)
▶$500KraisedSep 2014 · 7 investors · Pharmaceuticals
Rule 506(c)Officers, directors & promoters on the filing
- Alexander PolinskyDirector
- Thomas W GardnerExecutive Officer, Director
- Johan M SpoorDirector
- Paul DiPernaDirector
- Boris RatinerDirector
- Gary FreemanDirector
- Mark SelawskiExecutive Officer
- Fred KnollDirector
- Chaim DavisDirector
- Offering amount
- $1M
- Amount sold
- $500K
- First sale
- Sep 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06c
▶$1.9MraisedMar 2014 · 31 investors · PharmaceuticalsRule 506(b)
▶$1.9MraisedMar 2014 · 31 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Chaim DavisDirector
- Gary FreemanDirector
- Fred KnollDirector
- Boris RatinerDirector
- Johan M SpoorDirector
- Alexander PolinskyDirector
- Paul DiPernaDirector
- Thomas W. GardnerExecutive Officer, Director
- Mark SelawskiExecutive Officer
- Offering amount
- $2M
- Amount sold
- $1.9M
- Sales commissions
- $92.1K
- Placement agents
- Philadelphia Brokerage Corporation
- First sale
- Jan 2014
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has AtheroNova raised?
- AtheroNova has disclosed $2.4M raised across 2 rounds.
- Where is AtheroNova headquartered?
- AtheroNova is headquartered in Irvine, US.